Inmed Pharmaceuticals Inc (INM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.45% 1.1726	1.2402	0.9019	2.3111	1.0339
Cost Of Revenue	18.45% 0.8831	0.7456	0.7877	1.0085	0.8414
Gross Profit	10.70% 0.2895	0.3241	0.0212	1.5704	0.1925
Operating Expenses	8.36% 2.1338	1.9691	2.6941	2.0866	2.3417
Benefits Costs and Expenses	6.51% 2.8955	2.7184	3.4387	2.6477	3.0304
Costs And Expenses	6.51% 2.8955	2.7184	3.4387	19.77	-2.3417
Depreciation and Amortization	0.85% 0.0548	0.0552	0.0548	0.0535	0.0507
Operating Income/Loss	31.87% -0.9612	-0.7289	-2.5368	-0.3384	-1.9979
Income/Loss From Continuing Operations Before Tax	16.55% -1.7229	-1.4782	-2.5368	-0.3366	-1.9964
Income/Loss From Continuing Operations After Tax	16.55% -1.7229	-1.4782	-2.5368	-0.3497	-1.9964
Net Income/Loss	16.55% -1.7229	-1.4782	-2.5368	0.30	-1.9979
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	0.6384	-
Basic Average Shares	20.56% 9.613	7.9735	3.3282	0.2922	3.3282
Diluted Average Shares	20.56% 9.613	7.9735	3.3282	0.2922	3.3282
Basic Earnings Per Share	5.26% -0.18	-0.19	-0.76	0.28	-0.60
Diluted Earnings Per Share	5.26% -0.18	-0.19	-0.76	0.28	-0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%